Showing results (1271-1280 of 1,892) with videos related to

Sort By:
Pageof 190
Molecular Plant|February 15, 2019
PBS3 Protects EDS1 from Proteasome-Mediated Degradation in Plant ImmunityMing Chang, Jinping Zhao, Huan Chen, et al.
Circulation|March 29, 2001
Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failureD M McNamara, R Holubkov, K Janosko, et al.
BMC Genetics|July 2, 2003
Male preponderance in early diagnosed type 2 diabetes is associated with the ARE insertion/deletion polymorphism in the PPP1R3A locusAlex S F Doney, Bettina Fischer, Joanne E Cecil, et al.
American Journal of Human Genetics|June 15, 2007
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiencyM He, S L Rutledge, D R Kelly, et al.
Medical Teacher|April 29, 2018
A cross-sectional study of learning styles among continuing medical education participantsC Scott Collins, Sanjeev Nanda, Brian A Palmer, et al.
Biorxiv : the Preprint Server for Biology|July 14, 2025
Sex-specific transcriptional signatures of oxycodone persist during withdrawal and abstinence in the suprachiasmatic nucleus of heterogeneous stock ratsTara C Delorme, Snehal Sambare, Benjamin R Williams, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Biophysical mechanisms of morphogenesis in lizard lungsKaleb Hill, Aaron H Griffing, Michael A Palmer, et al.
International Journal of Nanomedicine|July 17, 2019
Selenium nanoparticles as anti-infective implant coatings for trauma orthopedics against methicillin-resistant <i>Staphylococcus aureus</i> and <i>epidermidis</i>: in vitro and in vivo assessmentPhong A Tran, Neil O'Brien-Simpson, Jason A Palmer, et al.
The American Journal of Pathology|December 7, 2007
Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesisJohn A Rophael, Randall O Craft, Jason A Palmer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2J G Scharenberg, A G Stam, B M von Blomberg, et al.
Pageof 190